New oral anticoagulants [Neue orale antikoagulanzien]

被引：0
|
作者：
Stoberock K. [1 ]
Debus E.S. [1 ]
Larena-Avellaneda A. [1 ]
Kieback A. [1 ]
机构：
[1] Klinik und Poliklinik für Gefäßmedizin, Universitäres Herzzentrum Hamburg, Martinistr. 52
来源：
Gefässchirurgie | 2013年 / 18卷 / 7期
关键词：
Apixaban; Dabigatran; Rivaroxaban; Stroke; Thromboembolism;
D O I：
10.1007/s00772-013-1186-9
中图分类号：
学科分类号：
摘要：
In recent years the new oral anticoagulants dabigatran, rivaroxaban and apixaban have been approved for the prevention of stroke and thromboembolism and also rivaroxaban for therapy of thromboembolism. Extensive studies have shown that in comparison to conventional medications these new substances reduce the risk of severe bleeding, in particular intracranial hemorrhage as well as of stroke and thromboembolism despite a moderate increase in minor bleeding. In addition the administration offers considerable advantages while the disadvantages appear to be manageable. © Springer-Verlag 2013.
引用
收藏
页码：665 / 674
页数：9
相关论文
共 50 条
  • [31] A New Generation of Oral Direct Anticoagulants
    Soff, Gerald A.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2012, 32 (03) : 569 - 574
  • [32] New oral anticoagulants: not quite there yet
    Karthikeyan, Ganesan
    Eikelboom, John W.
    Hirsh, Jack
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2009, 119 (1-2): : 53 - 58
  • [33] Hemorrhagic stroke and new oral anticoagulants
    Derlon, V.
    Corbonnois, G.
    Martin, M.
    Toussaint-Hacquard, M.
    Audibert, G.
    ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION, 2014, 33 (9-10): : 540 - 547
  • [34] Is there a role yet for new direct oral anticoagulants in cancer patients?
    Cohen, Abigail L.
    Lim, Chung S.
    Davies, Alun H.
    PHLEBOLOGY, 2016, 31 (03) : 157 - 159
  • [35] Prevention and treatment of venous tromboembolism: the place of new oral anticoagulants
    Reis, Abilio
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2012, 31 : 45 - 50
  • [36] New Oral Anticoagulants for Atrial Fibrillation: A Review of Clinical Trials
    O'Dell, Kate M.
    Igawa, Daniel
    Hsin, Jerline
    CLINICAL THERAPEUTICS, 2012, 34 (04) : 894 - 901
  • [37] The new oral anticoagulants
    Verheugt, F. W. A.
    NETHERLANDS HEART JOURNAL, 2010, 18 (06): : 314 - 318
  • [38] New oral anticoagulants
    Lozano, F. S.
    Arcelus, J. I.
    Monreal, M.
    ANGIOLOGIA, 2010, 62 (01): : 26 - 32
  • [39] Antikoagulation bei Vorhofflimmern: Neue AntikoagulanzienAnticoagulation for atrial defibrillation: new anticoagulants
    M. Moser
    C. Bode
    Der Kardiologe, 2012, 6 (2): : 148 - 156
  • [40] New oral anticoagulants
    Voeller, H.
    Alban, S.
    Westermann, D.
    INTERNIST, 2010, 51 (12): : 1571 - 1581
12345